Abstract
Isomeric compounds are characterized, on the one hand, by the proximity of the main physicochemical characteristics, including mass, NMR and IR spectra, and on the other hand, by significant differences in properties essential for a human being, for example, reactivity and toxicity. Virtually all known physicochemical methods of analysis are used to study and determine isomers; chromatography–mass spectrometry is among the most effective ones. Mass spectrometric identification includes library search, building the structure of a molecule based on fragmentation patterns for various classes of organic substances, and the use of special methods of ionization, yielding information about the structure of molecules. Chromatographic separation enables the identification of isomeric compounds with identical mass spectra. Information about the presence of specific isomers in their complex mixtures is necessary for making serious arbitral decisions in forensic science, toxicology, or doping analysis. The review discusses examples of using chromatography–mass spectrometry for isomer-specific analysis in antidoping control.
Similar content being viewed by others
REFERENCES
Prohibited List, January 2018. http://www.wada-ama.org/en/resources/science-medicine/prohibited-list-documents. Accessed April 10, 2018.
2018 Equine Prohibited Substances List. http://inside. fei.org/content/anti-doping-rules. Accessed April 10, 2018.
International Standard for Laboratories, ver. 9.0. http://www.wada-ama.org/en/resources/laboratories/ international-standard-for-laboratories-isl. Accessed April 10, 2018.
Anti-Doping Rule Violations (ADRVS) Report, 2015. http://www.wada-ama.org/en/resources/general-anti-doping-information/anti-doping-rule-violations-adrvs- report. Accessed April 10, 2018.
Dvorak, J., Saugy, M., and Pitsiladis, Y.P., Br. J. Sports Med., 2014, vol. 48, no. 10, p. 807.
Technical Document on the Minimum Criteria for Chromatographic–Mass Spectrometric Confirmation of the Identity of Analytes for Doping Control Purposes. http://www.wada-ama.org/en/resources/science-medicine/td2015idcr. Accessed April 10, 2018.
WADA: Anti-Doping Testing Figures, Montreal, Canada: Anti-Doping Agency Solely, 2015. http://www.wada-ama.org/en/resources/laboratories/anti-doping-testing-figures. Accessed April 10, 2018.
Kicman, A.T., Br. J. Pharmacol., 2008, vol. 154, no. 3, p. 502.
Technical Document for Minimum Required Performance Levels. WADA TD2018MRPL. http://www.wada-ama.org/sites/default/files/resources/files/ td2018mrpl_v1_finaleng.pdf. Accessed April 10, 2018.
Van Renterghem, P., Van Eenoo, P., Geyer, H., Schänzer, W., and Delbeke, F.T., Steroids, 2011, vol. 75, no. 2, p. 154.
Schänzer, W. and Donike, M., Anal. Chim. Acta, 1993, vol. 275, nos. 1–2, p. 23.
Parr, M.K. and Schänzer, W., J. Steroid Biochem. Mol. Biol., 2010, vol. 121, nos. 3–5, p. 528.
Donike, M. and Zimmermann, J., J. Chromatogr. A, 1980, vol. 202, p. 483.
Massé, R., Ayotte, C., and Dugal, R., J. Chromatogr. A, 1989, vol. 489, no. 1, p. 23.
Bi, H.G., Massé, R., and Just, G., Steroids, 1992, vol. 57, no. 9, p. 453.
Stanley, S.M., Smith, L., and Rodgers, J.P., J. Chromatogr. B: Biomed. Sci. Appl., 1997, vol. 690, nos. 1–2, p. 55.
Massé, R., Bi, H.G., Ayotte, C., Du, P., Gelinas, H., and Dugal, H., J. Chromatogr. A, 1991, vol. 562, nos. 1–2, p. 323.
Yamada, M., Aramaki, S., Kurosawa, M., Saito, K., and Nakazawa, H., J. Anal. Toxicol., 2008, vol. 32, no. 5, p. 87.
Bi, H.G. and Massé, R., J. Steroid Biochem. Mol. Biol., 1992, vol. 42, no. 5, p. 533.
Donike, M., Mareck-Engelke, U., and Rauth, S., in Proc. 12th Cologne Workshop on Dope Analysis, Köln, Germany: Sport und Buch Strausse Edition Sport, 1995, p. 157.
Ofterbro, H., Lancet, 1992, vol. 339, no. 8798, p. 941.
Mareck, U., Geyer, H., Opfermann, G., Thevis, M., and Schänzer, W., J. Mass Spectrom., 2008, vol. 43, no. 7, p. 877.
Zhang, Y., Tobias, H.J., Auchus, R.J., and Brenna, T.J., Drug Test. Anal., 2011, vol. 3, p. 857.
Piper, T. and Thevis, M.,Methods Enzymol., 2017, vol. 596, p. 403.
Piper, T., Emery, C., and Saugy, M., Anal. Bioanal. Chem., 2011, vol. 401, no. 2, p. 433.
Piper, T., Mareck, U., Geyer, H., Flenker, U., Thevis, M., Platen, P., and Schänzer, W., Rapid Commun. Mass Spectrom., 2008, vol. 22, no. 4, p. 2161.
Hebestreit, M., Flenker, U., Fusshöller, G., Geyer, H., Güntner, U., Mareck, U., Piper, T., Thevis, M., Ayotte, C., and Schänzer, W., Analyst, 2006, vol. 131, no. 9, p. 1021.
Piper, T., Geyer, H., Gougoulidis, V., Flenker, U., and Schänzer, W., Drug Test. Anal., 2010, vol. 2, no. 5, p. 217.
Gómez, C., Pozo, O.J., Geyer, H., Marcos, J., Thevis, M., Schänzer, W., Segura, J., and Ventura, R., J. Steroid Biochem. Mol. Biol., 2012, vol. 132, nos. 3–5, p. 239.
Casilli, A., Piper, T., de Oliveira, F.A., Padilha, M.C., Pereira, H.M., Thevis, M., and de Aquino Neto, F.R., Drug Test. Anal., 2016, vol. 8, nos. 11–12, p. 1204.
Robinson, N., Castella, V., Saudan, C., Sottas, P.-E., Schweizer, C., Dimo-Simonin, N., Mangin, P., and Saugy, M., Forensic Sci. Int., 2006, vol. 163, nos. 1–2, p. 148.
Thevis, M., Geyer, H., Mareck, U., Sigmund, G., Henke, J., Henke, L., and Schänzer, W., Anal. Bioanal. Chem., 2007, vol. 388, no. 7, p. 1539.
Bean, K.A. and Henion, J.D., J. Chromatogr. B: Biomed. Sci. Appl., 1997, vol. 690, nos. 1–2, p. 65.
Bowers, L.D. and Sanaullah, M., J. Chromatogr. B: Biomed. Sci. Appl., 1996, vol. 687, no. 1, p. 61.
Danaceau, J.P., Scott Morrison, M., and Slawson, M.H., J. Mass Spectrom., 2008, vol. 43, no. 7, p. 993.
Badoud, F., Grata, E., Boccard, J., Guillarme, D., Veuthey, J.L., Rudaz, S., and Saugy, M., Anal. Bioanal. Chem., 2011, vol. 400, no. 2, p. 503.
Guan, F., Uboh, C.E., Soma, L.R., You, Y., Liu, Y., and Li, X., J. Mass Spectrom., 2010, vol. 45, no. 11, p. 1270.
Cha, E., Jeong, E.S., Cha, S., and Lee, J., Anal. Chim. Acta, 2017, vol. 964, p. 123.
Bergés, R., Segura, J., Ventura, R., Fitch, K.D., Morton, A.R., Farré, M., Mas, M., and de la Torre, X., Clin. Chem., 2000, vol. 46, no. 9, p. 1365.
Polettini, A., Montagna, M., Segura, J., and de la Torre, X., J. Mass Spectrom., 1996, vol. 31, no. 1, p. 47.
Jacobson, G.A., Yee, K.C., Wood-Bakerb, R., and Waltersb, E.H., Drug Test. Anal., 2015, vol. 7, no. 2, p. 109.
Spyridaki, M.H.E., Tsitsimpikou, C.J., Siskos, P.A., and Georgakopoulos, C.G., J. Chromatogr. B: Biomed. Sci. Appl., 2001, vol. 758, no. 2, p. 311.
Deventer, K., Pozo, O.J., Van Eenoo, P., and Delbeke, F.T., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2009, vol. 877, no. 4, p. 369.
Chołbiński, P., Wicka, M., Kowalczyk, K., Jarek, A., Kaliszewski, P., Pokrywka, A., Bulska, E., and Kwiatkowska, D., Anal. Bioanal. Chem., 2014, vol. 406, no. 15, p. 3681.
Li, X., Uboh, C.E., and Soma, L.R., Rapid Commun. Mass Spectrom., 2014, vol. 28, no. 2, p. 217.
Glicksberg, L., Bryand, K., and Kerrigan, S., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2016, vol. 1035, p. 91.
Monfort, N., Martínez, L., Bergés, R., Segura, J., and Ventura, R., Drug Test. Anal., 2015, vol. 7, no. 9, p. 819.
Wang, S.M., Wang, T.C., and Giang, Y.S., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2005, vol. 816, nos. 1–2, p. 131.
Yu, J., Han, K.S., Lee, G., Paik, M.J., and Kim, K.R., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2010, vol. 878, no. 31, p. 3249.
Matabosch, X., Pozo, O.J., Pérez-Mañá, C., Farré, M., Marcos, J., Segura, J., and Ventura, R., Ther. Drug Monit., 2013, vol. 35, no. 1, p. 118.
Deventer, K. and Delbeke, F.T., Rapid Commun. Mass Spectrom., 2003, vol. 17, no. 18, p. 2107.
Thörngren, J.-O., Ostervall, F., and Garle, M., J. Mass Spectrom., 2008, vol. 43, no. 7, p. 980.
Badouda, F., Grataa, E., Perrenouda, L., Avoisa, L., Saugya, M., Rudazb, S., and Veutheyb, J.-L., J. Chromatogr. A, 2009, vol. 1216, no. 20, p. 4423.
Badoud, F., Grata, E., Perrenoud, L., Saugy, M., Rudaz, S., and Veuthey, J.L., J. Chromatogr. A, 2010, vol. 1217, no. 25, p. 4109.
Ho, E.N.M., Kwok, W.H., Wong, A.S.Y., and Wan, T.S.M., Drug Test. Anal., 2012, vol. 5, no. 7, p. 509.
Geyer, H., Parr, M.K., Koehler, K., Mareck, U., Schänzer, W., and Thevis, M., J. Mass Spectrom., 2008, vol. 43, no. 7, p. 892.
Maughan, R.J., J. Sports Sci., 2005, vol. 23, no. 9, p. 883.
Parr, M.K., Gütschow, M., Daniels, J., Opfermann, G., Thevis, M., and Schänzer, W., Steroids, 2009, vol. 74, no. 3, p. 322.
Thevis, M., Schänzer, W., Geyer, H., Thieme, D., Grosse, J., Rautenberg, C., Flenker, U., Beuck, S., Thomas, A., Holland, R., and Dvorak, J., Br. J. Sports Med., 2013, vol. 47, no. 2, p. 109.
Zhanga, J., Zhangb, Y., and Wang, Y., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2016, vol. 1039, p. 1.
Parr, M.K., Blokland, M.H., Liebetrau, F., Schmidt, A.H., Meijer, T., Stanic, M., Kwiatkowska, D., Waraksa, E., and Sterk, S.S., Food Addit. Contam., Part A, 2017, vol. 34, no. 4, p. 525.
Steel, R., Timms, M., Levina, V., and Vine, J., Drug Test. Anal., 2014, vol. 6, no. 9, p. 909.
Thevis, M., Thomas, A., Delahaut, P., Bosseloir, A., and Schänzer, W., Anal. Chem., 2006, vol. 78, no. 6, p. 1897.
Hess, C., Thomas, A., Thevis, M., Stratmann, B., Quester, W., Tschoepe, D., Madea, B., and Musshoff, F., Anal. Bioanal. Chem., 2012, vol. 404, nos. 6–7, p. 1813.
Thomas, A., Schänzer, W., and Thevis, M., Drug Test Anal., 2014, vol. 6, nos. 11–12, p. 1125.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated by O. Zhukova
Rights and permissions
About this article
Cite this article
Obukhova, E.N., Buryak, A.K. Determination of Isomers in Doping Control by Chromatography–Mass Spectrometry. J Anal Chem 74, 847–860 (2019). https://doi.org/10.1134/S1061934819090077
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1061934819090077